Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiac Catheterization I: Pre-Procedure Overview01:28

Cardiac Catheterization I: Pre-Procedure Overview

Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Saroglitazar for non-obese metabolic-dysfunction associated steatotic liver disease (MASLD): An open-label randomised controlled trial.

The Indian journal of medical research·2026
Same author

Palladium Supported on Polystyrene (Pd@PS) for the Catalytic Synthesis of 2,5-Dimethylfuran (2,5-DMF) From Biomass-Derived 5-Chloromethylfurfural (CMF) at Ambient Temperature.

Chemistry (Weinheim an der Bergstrasse, Germany)·2026
Same author

Assessment of IPD Patients' Knowledge and Attitudes Toward Telemedicine at Tertiary Care Hospital of Metro City.

Journal of pharmacy & bioallied sciences·2025
Same author

<i>Klebsiella pneumoniae</i> urinary tract infection: A multicentric study highlights significant regional variations in antimicrobial susceptibility across India.

IJID regions·2025
Same author

Energy-Barrier-less Synthesis of Hexaaza-trifuranacyclopentadecaphane-hexaene at Ambient Temperature.

Organic letters·2024
Same author

Assessment of change in antimicrobial susceptibility pattern of bacteria causing orthopaedic infections by sequential sampling: A prospective cohort study.

Journal of clinical orthopaedics and trauma·2024

Related Experiment Video

Updated: Jun 23, 2026

A Mouse 5/6th Nephrectomy Model That Induces Experimental Uremic Cardiomyopathy
07:52

A Mouse 5/6th Nephrectomy Model That Induces Experimental Uremic Cardiomyopathy

Published on: November 7, 2017

Cardiorenal syndrome.

Himanshu Sekhar Mahapatra1, Robert Lalmalsawma, Narendra Pal Singh

  • 1Department of Medicine, Lok Nayak Hospital and Maulana Azad Medical College, New Delhi, India. drhimanshu_cmo@yahoo.co.in

Iranian Journal of Kidney Diseases
|April 28, 2009
PubMed
Summary
This summary is machine-generated.

The cardiorenal connection highlights the complex interplay between heart and kidney failure, where dysfunction in one organ significantly impacts the other, leading to poor prognoses. Understanding these cardiorenal connectors is crucial for managing this syndrome.

More Related Videos

Normothermic Cardiac Arrest and Cardiopulmonary Resuscitation: A Mouse Model of Ischemia-Reperfusion Injury
10:25

Normothermic Cardiac Arrest and Cardiopulmonary Resuscitation: A Mouse Model of Ischemia-Reperfusion Injury

Published on: August 30, 2011

Related Experiment Videos

Last Updated: Jun 23, 2026

A Mouse 5/6th Nephrectomy Model That Induces Experimental Uremic Cardiomyopathy
07:52

A Mouse 5/6th Nephrectomy Model That Induces Experimental Uremic Cardiomyopathy

Published on: November 7, 2017

Normothermic Cardiac Arrest and Cardiopulmonary Resuscitation: A Mouse Model of Ischemia-Reperfusion Injury
10:25

Normothermic Cardiac Arrest and Cardiopulmonary Resuscitation: A Mouse Model of Ischemia-Reperfusion Injury

Published on: August 30, 2011

Area of Science:

  • Cardiology
  • Nephrology
  • Physiology

Background:

  • Concomitant heart and kidney failure presents a severe clinical challenge with a poor prognosis.
  • The intricate mechanisms underlying the cardiorenal interaction and kidney function deterioration are not fully understood.
  • The heart and kidneys work synergistically to regulate vital physiological functions like blood pressure and fluid balance.

Purpose of the Study:

  • To propose an extended model of the cardiorenal connection, building upon the Guytonian model of volume and blood pressure control.
  • To elucidate the complex multifactorial nature of cardiorenal syndrome.
  • To address the need for revised definitions and management strategies for cardiorenal syndrome.

Main Methods:

  • Conceptual extension of the Guytonian model to incorporate cardiorenal interactions.
  • Identification of key "cardiorenal connectors" including the renin-angiotensin-aldosterone system, nitric oxide/reactive oxygen species balance, sympathetic nervous system, and inflammation.
  • Review of existing understanding and proposed categorization by the World Congress of Nephrology.

Main Results:

  • The proposed cardiorenal connection model integrates regulatory actions with structural and functional changes in the heart and kidneys.
  • Imbalances in identified cardiorenal connectors can lead to the deterioration of both cardiac and kidney function, defining cardiorenal syndrome.
  • The World Congress of Nephrology advocates for a categorized definition of cardiorenal syndrome based on primary pathology and time frame.

Conclusions:

  • Cardiorenal syndrome involves a complex, closed-loop system where dysfunction in one organ system precipitates failure in the other.
  • Management requires careful consideration of medications that may impair kidney function, especially in at-risk patients.
  • Treatment decisions for cardiorenal dysfunction, particularly in diuretic-refractory, volume-loaded patients, are challenging and necessitate a personalized approach in the absence of definitive clinical trials.